You are here: Industry Insights > FRESENIUS

News List

Fresenius Medical Care North America Announces New President for Renal Therapies Group firstwordpharma
July 23, 2021
Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.
Fresenius makes a flurry of deals in Chinese dialysis clinics and hospitals fiercebiotech
December 29, 2018
Fresenius Medical Care has moved to dramatically widen its footprint in China’s dialysis market, acquiring large shares in multiple Chinese companies and hospital systems across the country.....
Akorn searches for new CEO after failed Fresenius merger pharmaphorum
December 12, 2018
US generics firm Akorn is searching for a new CEO in the wake of a failed merger with Fresenius Kabi last year.Akorn had been set to merge with Fresenius Kabi in 2017...
Delaware Supreme Court allows Fresenius to abandon Akorn acquisition pharmaceutical-technology
December 11, 2018
The Delaware Supreme Court in the US has ruled that German health care company Fresenius could legally back out of its acquisition of US-based Akorn....
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger fiercepharma
December 11, 2018
Akorn once again tried and failed to salvage its $4.3 billion merger with Fresenius. Delaware's top court ruled that Fresenius had nixed the deal legally after data problems cropped up, and in the wake of the decision, Akorn's CEO made his exit.
Akorn CEO Raj Rai resigns after US court permits Fresenius to exit merger deal firstwordpharma
December 10, 2018
Commenting on the news, Piper Jaffray analyst David Amsellem remarked that Rai's departure is good news for Akorn, noting that the drugmaker "could benefit from a new leadership team that is better versed in manufacturing operations and generics R&D."
US court affirms decision to permit Fresenius to withdraw from deal to buy Akorn firstwordpharma
December 10, 2018
The Delaware Supreme Court on Friday upheld a lower court ruling permitting Fresenius Kabi to terminate its agreement to acquire Akorn for more than $4 billion. Shares in the latter drugmaker were down as much as 37 percent on the news.
US court affirms decision to permit Fresenius to withdraw from deal to buy Akorn firstwordpharma
December 10, 2018
The Delaware Supreme Court on Friday upheld a lower court ruling permitting Fresenius Kabi to terminate its agreement to acquire Akorn for more than $4 billion. Shares in the latter drugmaker were down as much as 37 percent on the news.
Akorn fights to salvage Fresenius deal in top Delaware court fiercepharma
December 10, 2018
Akorn, desperate to cling to its now-abandoned buyout by Fresenius, has taken its case for the deal to Delaware Supreme Court. Its argument?
Fresenius focuses on data, computer lapses at Akorn in trial over $4.3B deal fiercepharma
July 27, 2018
A trial which will determine whether Germany’s Fresenius can cancel its $4.3 billion deal to buy out U.S. generics maker Akorn is focused on lapses in Akorn’s computer and data integrity.

Previous page 1 2 Next page